Success in trials for rheumatoid arthritis treatment

Israeli bio-tech Proteologics Ltd. announced successful results in its pre-clinical trial of the PRT0467 drug candidate for the treatment of rheumatoid arthritis. Injections of the drug in mice found a statistically significant reduction in the inflammation response.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *